Clinical Oncology: Case Reports

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Adriana PC Barrichello Author

Subjects of specialization
cancer,cancer oncology,Carcinogenesis

Affiliation
Division of Medical Oncology, Hospital Sirio-Liban

Biography

Dr. Adriana PC Barrichello is working as scientist and professor Division of Medical Oncology, Hospital Sirio-Libanês, Brasília-DF, Brazil. The author has specalization in cancer, cancer oncology, chemotherapy, Carcinogenesis


Publications

Case Report Open Access

Partial Response to Dual BRAF and MEK Inhibition in a Patient with BRAF-Mutant Pancreatic Acinar Cell Carcinoma Refractory to Chemotherapy: A Case Report and Review of the Literature

Author(s):

Adriana PC Barrichello, Allan AL Pereira, Maria Dirlei FS Begnami, Marcus Vinicius Grigolon, Eduarda SC Oliveira, and Gustavo S Fernandes

Introduction: Pancreatic Acinar Cell Carcinoma (PACC) is a rare subgroup of pancreatic neoplasms that has a better prognosis compared to Pancreatic Ductal Adenocarcinoma (PDAC). The more indolent evolution of the PACC makes surgical resection the standard treatment for localized disease. In metastatic disease, treatment is not well established. BRAF mutations have been detected in up to 13% of PACC, however, treatment with BRAF and/or MEK inhibitors has not yet been studied.

Case report: We present the case of a 73-year-old man, who has the diagnosis of BRAF-mutated metastatic PACC refractory to chemotherapy regimens. He underwent the combination of dabrafenib (selective BRAF inhibitor) and trametinib (selec... view more»

Abstract HTML PDF



Google Scholars / Researchers Sites

GET THE APP